Industry Fights FDA’s PMA Proposal For External Defibrillators

Makers of automated external defibrillators are vigorously opposed to FDA’s proposal to require PMAs for the devices. A petition submitted by Philips Healthcare asks the agency to reclassify the devices into class II with special controls.

More from Regulation

More from Policy & Regulation